Blockchain Registration Transaction Record

Lantern Pharma Appoints Oncology Expert to Board, Boosting AI-Driven Cancer Research

Lantern Pharma enhances its board with Dr. Lee T. Schalop, aiming to accelerate AI-driven oncology drug development and bring innovative cancer treatments to market faster.

This development is crucial as it highlights the intersection of artificial intelligence and healthcare, specifically in the fight against cancer. Lantern Pharma's innovative use of AI to streamline drug discovery and development could lead to faster, more cost-effective treatments for patients with limited options. The appointment of Dr. Schalop, with his extensive experience in biotechnology and strategic transactions, signals a strong future for the company's oncology programs, potentially bringing hope to millions affected by cancer worldwide.